Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Forced chemotherapy in a teen: Exploring the ethics

Ruth Macklin, PhD
Conditions
January 16, 2015
Share
Tweet
Share

The case of Cassandra C., a 17-year-old in Connecticut who refused to continue receiving chemotherapy to treat her Hodgkin’s lymphoma, poses a genuine ethical dilemma. The dilemma stems from a conflict between two leading ethical principles. One principle, respect for autonomy, calls for respecting individuals’ right to self-determination. In the medical context, that means allowing people to refuse medical treatment, even lifesaving therapy. The other ethical principle, beneficence, directs physicians and hospitals to maximize benefits and minimize harms in caring for patients.

The problem in Cassandra’s case is that she is still legally a minor, which means that a parent or guardian has the legal authority to make health care decisions on her behalf. But unlike problematic cases in which parents and their offspring disagree about medical treatment, Cassandra’s mother upheld her daughter’s refusal of treatment.

Court decisions to date

Courts have the authority to overrule parents when their medical decisions threaten the life or health of their offspring. In such cases, temporary custody is removed from the parents and a specific guardian (termed a “guardian ad litem”) is appointed to make medical decisions for the minor.

On January 8, 2015, the Connecticut Supreme Court upheld a lower court decision and ruled that Cassandra must continue to undergo chemotherapy against her will. Separate lawyers for the mother and daughter sought to have the teen considered a “mature minor,” which would grant her the right to refuse lifesaving treatment, but the court declined to rule on that aspect, siding with the medical judgment that there is an 85 percent chance of surviving Hodgkin’s lymphoma by treating with chemotherapy.

Years ago at Albert Einstein College of Medicine we had a neonatal ethics committee that advised physicians in ethically troubling cases. A leading principle used in the committee’s deliberations was the following: “Parents are presumed to be the decision-makers for their children unless their decision is clearly against the best interest of the child.” The committee spent considerable effort seeking to determine when a parental decision was clearly against the infant’s best interest. Newborns and young children cannot make such judgments for themselves, but what about a teen who will reach the age of majority within a year?

Exploring the ethics

The legal barrier to respecting Cassandra’s autonomy remains, but the ethics of the case are murky. If this were a one-shot treatment — perhaps painful or uncomfortable, but over quickly — it would be easy to conclude that forced medical treatment would do more good than harm. But that is not clearly the case when the patient has to endure for as long as six months the discomforts of chemotherapy.

In December Cassandra first underwent surgery to install in her chest a port through which the drugs would be administered. State officials took custody of Cassandra and confined her in the hospital, Connecticut Children’s Medical Center, where she has received the forced treatments. Her cell phone was taken away (for a teen, this may be worse than the nausea and vomiting), and the phone in her hospital room was also removed. Her mother has been allowed to visit her in her hospital room, but only with a child welfare worker present. Mother and daughter are not allowed to have contact by phone.

In an op-ed piece published in the Hartford Courant, Cassandra said that the Connecticut Department of Children and Families had had her medically evaluated and placed in a foster home until the court date. Describing her ordeal once she was confined to the hospital for the forced treatment, she wrote: “I was strapped to a bed by my wrists and ankles and sedated.”

Uncertain resolution

There is no way of knowing what Cassandra will say if she is eventually cured of her cancer. She might be grateful that her life was saved and thank the doctors and the hospital for involving the courts to force the chemotherapy. Or she might remain resentful, claiming that her autonomous right to refuse medical treatment was violated. But whatever she might say, her judgment in the matter does not resolve the ethical dilemma. She is still legally a minor, but that does not ethically justify the actions of the doctor, the hospital, the child welfare agency, and the Connecticut courts. Although reasonable people may disagree on whether a 17-year-old should be forced to undergo medical treatment against her will, we should not condone the brutality involved in placing this young patient in a foster home, sedating her and strapping her down in a hospital bed. The philosopher Immanuel Kant wrote that “whoever wills the end, wills the means.” However, even those who initially support a plan to force treatment on a young patient are morally bound to question the means required to do so.

Ruth Macklin is a professor, department of epidemiology and population health, Albert Einstein College of Medicine, Bronx, NY. She blogs at The Doctor’s Tablet.

Prev

Top stories in health and medicine, January 16, 2015

January 16, 2015 Kevin 0
…
Next

Treating mild hypertension: The benefits are being questioned

January 16, 2015 Kevin 27
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Top stories in health and medicine, January 16, 2015
Next Post >
Treating mild hypertension: The benefits are being questioned

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Ruth Macklin, PhD

  • Is the National Institutes of Health stifling academic freedom?

    Ruth Macklin, PhD
  • How can we fix the research bias from industry sponsorship?

    Ruth Macklin, PhD
  • The erosion of informed consent in medical research

    Ruth Macklin, PhD

Related Posts

  • The ethics of rationing care during COVID

    M. Bennet Broner, PhD
  • Generics aren’t going to help the cost of chemotherapy drugs

    Peter Ubel, MD
  • Medical ethics and medical school: a student’s perspective

    Jacob Riegler
  • Exploring 2 roads to universal health coverage

    Cody Mullens
  • Nobody should ever be forced to make a medical decision on the basis of congressional hearings

    Anonymous
  • A patient’s experience of chemotherapy and radiation

    Lynn Lazos

More in Conditions

  • 5 cancer myths that could delay your diagnosis or treatment

    Joseph Alvarnas, MD
  • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

    Oluyemisi Famuyiwa, MD
  • What one diagnosis can change: the movement to make dining safer

    Lianne Mandelbaum, PT
  • How kindness in disguise is holding women back in academic medicine

    Sylk Sotto, EdD, MPS, MBA
  • Measles is back: Why vaccination is more vital than ever

    American College of Physicians
  • Hope is the lifeline: a deeper look into transplant care

    Judith Eguzoikpe, MD, MPH
  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast
    • 5 cancer myths that could delay your diagnosis or treatment

      Joseph Alvarnas, MD | Conditions
    • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

      Oluyemisi Famuyiwa, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 10 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • The hidden cost of becoming a doctor: a South Asian perspective

      Momeina Aslam | Education
    • Physician patriots: the forgotten founders who lit the torch of liberty

      Muhamad Aly Rifai, MD | Physician
    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • How scales of justice saved a doctor-patient relationship

      Neil Baum, MD | Physician
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • If I had to choose: Choosing the patient over the protocol

      Patrick Hudson, MD | Physician
    • How a TV drama exposed the hidden grief of doctors

      Lauren Weintraub, MD | Physician
    • Why adults need to rediscover the power of play

      Anthony Fleg, MD | Physician
    • How collaboration across medical disciplines and patient advocacy cured a rare disease [PODCAST]

      The Podcast by KevinMD | Podcast
    • 5 cancer myths that could delay your diagnosis or treatment

      Joseph Alvarnas, MD | Conditions
    • When bleeding disorders meet IVF: Navigating von Willebrand disease in fertility treatment

      Oluyemisi Famuyiwa, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Forced chemotherapy in a teen: Exploring the ethics
10 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...